RHOEN-KLINIK.UNSP.ADR 1/2 (RHKU) - Total Assets
Based on the latest financial reports, RHOEN-KLINIK.UNSP.ADR 1/2 (RHKU) holds total assets worth €1.86 Billion EUR (≈ $2.18 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore RHOEN-KLINIK.UNSP.ADR 1/2 (RHKU) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
RHOEN-KLINIK.UNSP.ADR 1/2 - Total Assets Trend (2021–2024)
This chart illustrates how RHOEN-KLINIK.UNSP.ADR 1/2's total assets have evolved over time, based on quarterly financial data. See RHOEN-KLINIK.UNSP.ADR 1/2 (RHKU) net assets for net asset value and shareholders' equity analysis.
RHOEN-KLINIK.UNSP.ADR 1/2 - Asset Composition Analysis
Current Asset Composition (December 2024)
RHOEN-KLINIK.UNSP.ADR 1/2's total assets of €1.86 Billion consist of 48.7% current assets and 51.3% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 15.1% |
| Accounts Receivable | €226.90 Million | 12.2% |
| Inventory | €37.46 Million | 2.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €8.53 Million | 0.5% |
| Goodwill | €165.40 Million | 8.9% |
Asset Composition Trend (2021–2024)
This chart illustrates how RHOEN-KLINIK.UNSP.ADR 1/2's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see RHOEN-KLINIK.UNSP.ADR 1/2 market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: RHOEN-KLINIK.UNSP.ADR 1/2's current assets represent 48.7% of total assets in 2024, an increase from 36.7% in 2021.
- Cash Position: Cash and equivalents constituted 15.1% of total assets in 2024, up from 7.6% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, a decrease from 9.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 12.2% of total assets.
RHOEN-KLINIK.UNSP.ADR 1/2 Competitors by Total Assets
Key competitors of RHOEN-KLINIK.UNSP.ADR 1/2 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Fresenius SE & Co. KGaA
XETRA:FRE
|
Germany | €42.46 Billion |
|
Ramsay Health Care Ltd
AU:RHC
|
Australia | AU$21.70 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.11 Billion |
|
HealWELL AI Inc.
TO:AIDX
|
Canada | CA$278.35 Million |
|
YONGHE MED.GR.DL-0000025
F:L97
|
Germany | €1.70 Billion |
|
Regis Healthcare Ltd
AU:REG
|
Australia | AU$2.11 Billion |
|
Oceania Healthcare Ltd
AU:OCA
|
Australia | AU$3.01 Billion |
|
Pacific Smiles Group Ltd
AU:PSQ
|
Australia | AU$163.53 Million |
RHOEN-KLINIK.UNSP.ADR 1/2 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.34 | 2.35 | 2.35 |
| Quick Ratio | 2.25 | 2.26 | 2.26 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €535.88 Million | €508.13 Million | €508.13 Million |
RHOEN-KLINIK.UNSP.ADR 1/2 - Advanced Valuation Insights
This section examines the relationship between RHOEN-KLINIK.UNSP.ADR 1/2's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.62 |
| Latest Market Cap to Assets Ratio | 0.43 |
| Asset Growth Rate (YoY) | 4.9% |
| Total Assets | €1.86 Billion |
| Market Capitalization | $803.26 Million USD |
Valuation Analysis
Below Book Valuation: The market values RHOEN-KLINIK.UNSP.ADR 1/2's assets below their book value (0.43x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: RHOEN-KLINIK.UNSP.ADR 1/2's assets grew by 4.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for RHOEN-KLINIK.UNSP.ADR 1/2 (2021–2024)
The table below shows the annual total assets of RHOEN-KLINIK.UNSP.ADR 1/2 from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €1.86 Billion ≈ $2.17 Billion |
+4.85% |
| 2023-12-31 | €1.77 Billion ≈ $2.07 Billion |
+3.85% |
| 2022-12-31 | €1.70 Billion ≈ $1.99 Billion |
+2.36% |
| 2021-12-31 | €1.67 Billion ≈ $1.95 Billion |
-- |
About RHOEN-KLINIK.UNSP.ADR 1/2
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, provides in-patient, semi-patient, and outpatient healthcare services in Germany. The company also operates acute hospitals, medical care centers, and rehabilitation hospitals. RHÖN-KLINIKUM Aktiengesellschaft was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.